hCG-activated PBMC-therapy in RIF Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 7, 2017

Primary Completion Date

September 25, 2018

Study Completion Date

July 11, 2019

Conditions
Recurrent Implantation Failure
Interventions
OTHER

Peripheral Blood Monouclear Cell

Blood samples (20 mL) were taken from individual patients at the time of ovulation induction. Then PBMC were isolated and cultured (20-30 million cells) 48 hour at the presence of hCG (10IU/ml daily). Afterward,15-20 million PBMCs in 500 microlitres PBS were injected into the uterine cavity two days before embryo transfer (ET) using ET catheter.

OTHER

Phosphate Baffer Saline

Only 500 microlitres PBS will be injected into the uterine cavity, instead of PBMCs, two days before embryo transfer (ET) using ET catheter.

Trial Locations (1)

Unknown

Valiasr Hospital, Tabriz

All Listed Sponsors
lead

SCARM Institute, Tabriz, Iran

OTHER_GOV

NCT03267797 - hCG-activated PBMC-therapy in RIF Patients | Biotech Hunter | Biotech Hunter